HOT PRODUCTS

Peripheral Intervention

Cardiovascular Intervention

Customization

Intracranial Aspiration Catheter

The intracranial aspiration catheter is designed to work as a support device to facilitate thrombectomy. It‘s intended for use in the removal/aspiration of emboli and thrombi from selected blood vessels in the neurovasculatures.

Learn More Learn More

Neuro Microcatheter

This product is intended for the selective delivery of liquids and/or other instruments or agents to target sites into the neurovascular during diagnostic and/or therapeutic procedures.

Learn More Learn More

Neuro Long Sheath

This product is intended for establishing a stable channel from the skin to the proximal target vessel, protect the puncture site and reduce vascular injury. It also provides a stable proximal support point for subsequent guiding catheters and intermediate catheters.

Learn More Learn More

Steerable Catheter

We develop and manufacture standard or customized configurations of steerable catheter delivery systems to meet your device needs. From concept to manufacturing, we offer full-service steerable catheter production.

Learn More Learn More

PRICE INQUIRY

We rely on our rich industry experience and cutting-edge technological knowledge, starting from the purpose, usage environment, and specification requirements of the catheter, comprehensively considering various factors, aiming to provide customers with better solutions and ensure stability in practical applications.

Instant inquiry →

9400 ㎡

Company factory area

20 +

Years of industry experience

30 +

Product Category

200 +

Number of company personnel

We have professional design support

Equipped with precision pipeline equipment such as imported extruders, imported weaving machines, imported welding machines, and corresponding testing equipment such as laser calipers.

Certificated by ISO 13485
Equipped with independent P&C Lab

ABOUT KEYSEE

Shanghai Keysee Medtech Co., Ltd. was founded in 2022 and is located in the North Shanghai Biomedical Industrial Park. Its wholly-owned subsidiary, Jiangsu Keysee Medtech Co., Ltd.,was registered and established in Haian High-tech Zone, Nantong City, Jiangsu Province in 2024. The company has gathered a group of product R&D and design talents and lean production teams who are deeply engaged in the field of interventional and implantable devices. It is a high-tech enterprise specializing in OEM and ODM services in the field of vascular interventional devices.

OEM&ODM manufacturing enterprises

NEWS & ARTICLES

We stay proactive and think big. Stay informed about our latest research news.

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

2026-02-27

Pharmaceutical and Biotechnology Industry Watch: Innovative Drugs and Medical Devices Fuel a Structured Market Rally; AI in Healthcare Opens Up New Growth Opportunities

During the third week of February 2025, the pharmaceutical and biotechnology sector continued to exhibit structural divergence. Over the week, the pharmaceutical and biotechnology index rose by 1.88%, outperforming both the CSI 300 Index and the Shanghai Composite Index, ranking ninth in terms of sector performance.

2026-02-27

Pharmaceutical and Biotechnology Industry Watch: AI-Driven Healthcare Applications Accelerate Deployment; Breakthroughs in Payment-Policy for Innovative Drugs

Recently, the pharmaceutical and biotechnology sector has exhibited a pronounced structural market trend, driven by the deep integration of AI technologies with healthcare applications, which is spurring industry-wide upgrades. At the same time, policy support for innovative drugs continues to strengthen, creating multiple favorable factors for the sector.

Messages

Committed to contributing to global clinical medicine through technological innovation and lean production

We uphold the corporate culture of "contributing to global clinical medicine through technological innovation and lean production", relying on our experienced R&D team and exquisite manufacturing technology to help customers quickly achieve high-quality device research and commercialization.

mkt001@keyseemed.com